Methods of reducing weight gain associated with olanzapine treatment
US7737165B2 · kind B2 · utility
2Cited by
3References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 22, 2005 |
| Grant date | Jun 15, 2010 |
| Priority date | — |
| Expiry date | Nov 22, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of reducing weight gain associated with olanzapine treatment in a human subject, by orally administering to an olanzapine-treated subject betahistine or a salt thereof, is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.